Elicio Therapeutics, Inc. (ELTX) Free Cash Flow by Year
Elicio Therapeutics, Inc. recorded an outflow of $37.0M in free cash flow in fiscal year 2025. This represents an increase of 0.5% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Elicio Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ELTX Free Cash Flow by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ELTX Free Cash Flow by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What free cash flow means
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.
More Elicio Therapeutics, Inc. financials
Frequently Asked Questions
What was Elicio Therapeutics, Inc.'s free cash flow in fiscal year 2025?
Elicio Therapeutics, Inc. recorded an outflow of $37.0M in free cash flow in fiscal year 2025.
How fast is Elicio Therapeutics, Inc.'s free cash flow growing?
Elicio Therapeutics, Inc. (ELTX) free cash flow rose by 0.5% year over year, from -$37.2M to -$37.0M in fiscal year 2025.
How has Elicio Therapeutics, Inc.'s free cash flow changed over the years?
Across the 6 fiscal years this page covers, Elicio Therapeutics, Inc. (ELTX) free cash flow went from -$22.9M in fiscal year 2020 to -$37.0M in fiscal year 2025.
What does free cash flow mean on a financial statement?
Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Elicio Therapeutics, Inc. (ELTX) reported on that line in every period on record.